In addition, the close structural similarity of exon 20 of EGFR and receptor tyrosine-protein kinase erbB-2 (ERBB2) indicates that our findings could be applicable to ERBB2 mutated lung cancer [10]. Here, ERBB2 is linked to lung carcinoma.